Form 4 for NVCR NovoCure Ltd
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0001562180-24-004824 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-06-07 | 2024-06-05 | NVCR | GROENHUYSEN WILHELMUS CM | COO | M - OptEx | $22.82 | +124.4K | 124.4K | New | +$2.84M |
| DI | 2024-06-07 | 2024-06-05 | NVCR | GROENHUYSEN WILHELMUS CM | COO | M - OptEx | $22.82 | -124.4K | 95.0K | -57% | -$2.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-06-05 | M | A | 124,373 | $22.82 | 124,373 | I The 2020 Groenhuysen Annuity Trust | — | — | |
| 2 | Derivative | Stock Options (Right to buy) | 2024-06-05 | M | D | 124,373 | $22.82 | 95,000 | I The 2020 Groenhuysen Annuity Trust | $7.15 · — to 2027-02-21 | 124,373 Ordinary Shares | (F2) By The 2020 Groenhuysen Annuity Trust. Mr. Groenhuysen does not disclaim beneficial ownership. (F1) Options to buy 219,372 ordinary shares will vest in equal installments on each of February 22, 2018, 2019 and 2020, subject to the reporting person's continued employment through such dates. |